Akari Therapeutics, Plc Public Float
Akari Therapeutics, Plc (AKTX) had Public Float of $15.00 million as of 2025-06-30, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-30
- 2025-06-30: Entity Public Float $15.00M.
- 2024-06-30: Entity Public Float $14.00M.
- 2023-06-30: Entity Public Float $13.60M.
- 2015-06-30: Entity Public Float $31.19M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $15.00M 10-K · filed 2026-03-30 |
| 2024-06-30 | $14.00M 10-K · filed 2025-04-15 |
| 2023-06-30 | $13.60M 10-K · filed 2024-03-29 |
| 2015-06-30 | $31.19M 10-K · filed 2016-03-23 |
| 2014-06-30 | $34.49M 10-K · filed 2015-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |